Commercially available rapid diagnostic tests for the detection of high priority pathogens: status and challenges - Analyst (RSC Publishing) DOI:10.1039/D0AN02286A
Commercially available rapid diagnostic tests for the detection of high priority pathogens: status and challenges - Analyst (RSC Publishing) DOI: 10.1039/D0AN02286A
Commercially available rapid diagnostic tests for the detection of high priority pathogens: status and challenges - Analyst (RSC Publishing) DOI: 10.1039/D0AN02286A
Diagnostics, Free Full-Text
Diagnostic tests to mitigate the antimicrobial resistance pandemic—Still the problem child
Point of Care Sensors for Infectious Pathogens
Commercially available rapid diagnostic tests for the detection of high priority pathogens: status and challenges - Analyst (RSC Publishing) DOI: 10.1039/D0AN02286A
PDF] Commercially available rapid diagnostic tests for the detection of high priority pathogens: status and challenges.
Commercially available rapid diagnostic tests for the detection of high priority pathogens: status and challenges - Analyst (RSC Publishing) DOI: 10.1039/D0AN02286A
Diagnostic assay and technology advancement for detecting SARS-CoV-2 infections causing the COVID-19 pandemic
Commercially available rapid diagnostic tests for the detection of high priority pathogens: status and challenges - Analyst (RSC Publishing) DOI: 10.1039/D0AN02286A
PDF] Commercially available rapid diagnostic tests for the detection of high priority pathogens: status and challenges.
REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes
Diagnostics for COVID-19: moving from pandemic response to control - The Lancet
Recent advances in antibiotic resistance diagnosis using SERS: focus on the “ Big 5 ” challenges - Analyst (RSC Publishing) DOI:10.1039/D2AN00703G
Rapid Diagnostic Test Value and Implementation in Antimicrobial Stewardship Across Low-to-Middle and High-Income Countries: A Mixed-Methods Review
